These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Using the Localized Scleroderma Cutaneous Assessment Tool (LoSCAT) to classify morphoea by severity and identify clinically significant change. Teske NM; Jacobe HT Br J Dermatol; 2020 Feb; 182(2):398-404. PubMed ID: 31049928 [TBL] [Abstract][Full Text] [Related]
9. Unravelling morphoea aetiopathogenesis by next-generation sequencing of paired skin biopsies. Saracino AM; Kelberman D; Otto GW; Gagunashvili A; Abraham DJ; Denton CP Arch Dermatol Res; 2023 Sep; 315(7):2035-2056. PubMed ID: 36912952 [TBL] [Abstract][Full Text] [Related]
10. Children with facial morphoea managing everyday life: a qualitative study. Stasiulis E; Gladstone B; Boydell K; O'Brien C; Pope E; Laxer RM Br J Dermatol; 2018 Aug; 179(2):353-361. PubMed ID: 29451694 [TBL] [Abstract][Full Text] [Related]
11. Prospective evaluation of frequency of signs of systemic sclerosis in 76 patients with morphea. Lipsker D; Bessis D; Cosnes A; Kluger N; Lutz V; Sauleau E; Francès C Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S23-5. PubMed ID: 25797524 [TBL] [Abstract][Full Text] [Related]
12. Risk factors for morphoea disease severity: a retrospective review of 114 paediatric patients. Pequet MS; Holland KE; Zhao S; Drolet BA; Galbraith SS; Siegel DH; Chiu YE Br J Dermatol; 2014 Apr; 170(4):895-900. PubMed ID: 24341905 [TBL] [Abstract][Full Text] [Related]
13. Morphoea is neither associated with features of Borrelia burgdorferi infection, nor is this agent detectable in lesional skin by polymerase chain reaction. Weide B; Schittek B; Klyscz T; Schüz K; Stark M; Rassner G; Wilske B; Garbe C Br J Dermatol; 2000 Oct; 143(4):780-5. PubMed ID: 11069456 [TBL] [Abstract][Full Text] [Related]
14. Is morphoea caused by Borrelia burgdorferi? A review. Weide B; Walz T; Garbe C Br J Dermatol; 2000 Apr; 142(4):636-44. PubMed ID: 10792212 [TBL] [Abstract][Full Text] [Related]
15. [Linear scleroderma in children (apropos of 27 cases)]. Larrègue M; Ziegler JE; Lauret P; Bonafe J; Lorette G; Titi A; Ramdenee P; Bressieux JM Ann Dermatol Venereol; 1986; 113(3):207-24. PubMed ID: 3752860 [TBL] [Abstract][Full Text] [Related]
16. Increased central cornea thickness in localized scleroderma (morphoea). Serup J; Serup L Metab Pediatr Syst Ophthalmol (1985); 1985; 8(2-3):11-4. PubMed ID: 3870939 [TBL] [Abstract][Full Text] [Related]
17. Skin biopsy analysis of concurrent keloidal morphoea and systemic sclerosis confirms overlapping pathogenic pathways. Clark KEN; Gak N; Orteu CH; Ong VH; Derrett-Smith EC; Denton CP Clin Exp Rheumatol; 2023 Aug; 41(8):1644-1651. PubMed ID: 37223904 [TBL] [Abstract][Full Text] [Related]
18. Morphoea: a manifestation of infection with Borrelia species? Eisendle K; Grabner T; Zelger B Br J Dermatol; 2007 Dec; 157(6):1189-98. PubMed ID: 17941947 [TBL] [Abstract][Full Text] [Related]
19. First case series on the use of imiquimod for morphoea. Dytoc M; Ting PT; Man J; Sawyer D; Fiorillo L Br J Dermatol; 2005 Oct; 153(4):815-20. PubMed ID: 16181467 [TBL] [Abstract][Full Text] [Related]
20. Localized morphoea preceded by a pigmented purpuric dermatosis. Bell HK; Dobson CM; Jackson SP; King CM Clin Exp Dermatol; 2003 Jul; 28(4):369-71. PubMed ID: 12823294 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]